Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza

Journal of the Royal Society Interface

Volumn 10, Issue 81, 2013, Pages

  Black, Andrew J ^a   House, Thomas ^b   Keeling, M J ^b   Ross, J V ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

A(H1N1)pdm; Bayesian; Doubling time; Markov chain; R*

Indexed keywords

MARKOV PROCESSES;

ANTIVIRAL PROPHYLAXIS; ANTIVIRAL TREATMENTS; BAYESIAN; COMPUTATIONALLY EFFICIENT; DOUBLING TIME; PANDEMIC INFLUENZA; POPULATION-LEVEL EFFECTS; R;

DISEASE CONTROL;

INFLUENZA VACCINE; ANTIVIRUS AGENT;

ACCURACY; ANTIVIRAL THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; EARLY DIAGNOSIS; HEALTH CARE DELIVERY; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); MATHEMATICAL MODEL; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; THERAPY DELAY; BAYES THEOREM; BIOLOGICAL MODEL; FAMILY SIZE; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC;

ANTIVIRAL AGENTS; BAYES THEOREM; FAMILY CHARACTERISTICS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; PANDEMICS;

MLCS; MLOWN;

EID: 84875699182     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2012.1019     Document Type: Article

References (39)

1. Russell CA et al. 2012 The potential for respiratory droplet- transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336, 1541-1547. (doi:10.1126/science.1222526)
2. Fraser C, Riley S, Anderson R, Ferguson N. 2004 Factors that make an infectious disease outbreak controllable. Proc. Natl Acad. Sci. USA 101, 6146-6151. (doi:10.1073/pnas.0307506101)
3. Longini IM, Halloran ME, Nizam A, Yang Y. 2004 Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 159, 623-633. (doi:10.1093/aje/kwh092)
4. Wu JT, Riley S, Fraser C, Leung GM. 2006 Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med. 3, e361. (doi:10.1371/journal.pmed.0030361)
5. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J. 2004 Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J. Infect. Dis. 189, 440-449. (doi:10.1086/381128)
6. Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS. 2007 Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am. J. Epidemiol. 165, 212-221. (doi:10.1093/aje/kwj362)
7. Riley S. 2007 Large-scale spatial-transmission models of infectious disease. Science 316, 1298-1301. (doi:10.1126/science.1134695)
8. House T, Keeling MJ. 2008 Deterministic epidemic models with explicit household structure. Math. Biosci. 213, 29-39. (doi:10.1016/j.mbs.2008.01.011)
9. Ball F, Mollison D, Scalia-Tomba G. 1997 Epidemics with two levels of mixing. Ann. Appl. Probab. 1, 46-89. (doi:10.1214/aoap/1034625252)
10. Ross JV, House T, Keeling MJ. 2010 Calculation of disease dynamics in a population of households. PLoS ONE 3, e9666. (doi:10.1371/journal. pone.0009666)
11. Ball FG, Lyne OD. 2002 Optimal vaccination policies for stochastic epidemics among a population of households. Math. Biosci. 177-178, 333-354. (doi:10.1016/S0025-5564(01)00095-5)
12. Longini IM, Koopman JS. 1982 Household and community transmission parameters from final distributions of infections in households. Biometrics 38, 11-126.
13. Glass K, McCaw JM, McVernon J. 2011 Incorporating population dynamics into household models of infectious disease transmission. Epidemics 3, 152-158. (doi:10.1016/j.epidem. 2011.05.001)
14. Keeling MJ et al. 2001 Dynamics of the 2001 UK foot and mouth epidemics: stochastic dispersal in a heterogeneous landscape. Science 294, 813-817. (doi:10.1126/science.1065973)
15. Longini IM, Nizam A, Xu S, Ungchsak K, Hanshaoworakul W, Cummings DAT, Halloran ME. 2005 Containing pandemic influenza at the source. Science 309, 1083-1087. (doi:10.1126/science.1115717)
16. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. 2006 Strategies for mitigating an influenza pandemic. Nature 442, 448-452. (doi:10.1038/nature04795)
17. Germann TC, Kadau K, Longini IM, Macken CA. 2006 Mitigation strategies for pandemic influenza in the United States. Proc. Natl Acad. Sci. USA 103, 5935-5940. (doi:10.1073/pnas.0601266103)
18. Carrat F, Luong J, Lao H, Salle A-V, Lajaunie C, Wackernagel H. 2006 A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med. 4, 26. (doi:10.1186/1741-7015-4-26)
19. Halloran ME et al. 2008 Modeling targeted layered containment of an influenza pandemic in the United States. Proc. Natl Acad. Sci. USA 105, 4639-4644. (doi:10.1073/pnas.0706849105)
20. Fraser C. 2007 Estimating individual and household reproduction numbers in an emerging epidemic. PLoS ONE 2, e758. (doi:10.1371/journal.pone.0000758)
21. Becker NG, Wang D. 2011 Can antiviral drugs contain pandemic influenza? PLoS ONE 6, e17764. (doi:10.1371/journal.pone.0017764)
22. Spencer SEF, O'Neill PD. 2012 Assessing the impact of intervention delays on stochastic epidemics. Methodol. Comput. Appl. Probab. 6. (doi:10.1007/s11009-012-9278-7)
23. Donnelly CA et al. 2011 Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A(H1N1): implications for influenza control recommendations. Clin. Infect. Dis. 52(Suppl. 1), S123-S130. (doi:10.1093/cid/ciq028)
24. House T, Inglis N, Ross JV, Wilson F, Suleman S, Edeghere O, Smith G, Olowokure B, Keeling MJ. 2012 Estimation of outbreak severity and transmissibility: influenza A(H1N1)pdm09 in households. BMC Med. 10, 117. (doi:10.1186/1741-7015-10-117)
25. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ. 2012 Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst. Rev. 1, CD008965. (doi:10.1002/14651858.CD008965.pub3)
26. House T et al. 2011 Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc. R. Soc. B 278, 2753-2760. (doi:10.1098/rspb.2010.2688)
27. Baguelin M, van Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. 2010 Vaccination against pandemic influenza A/H1N1v in England: a realtime economic evaluation. Vaccine 28, 2370-2384. (doi:10.1016/j.vaccine.2010.01.002)
28. Anderson D, Watson R. 1980 On the spread of a disease with gamma distributed latent and infectious periods. Biometrika 67, 191-198. (doi:10.1093/biomet/67.1.191)
29. Ghani AC et al. 2009 The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Curr. RRN1130. (doi:10.1371/currents.RRN1130)
30. Keeling M, Rohani P. 2008 Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press.
31. Anderson R, May R. 1992 Infectious diseases of humans. Oxford, UK: Oxford University Press.
32. Epistruct: Matlab routines for epidemic modelling and inference in structured populations. See http://sourceforge.net/projects/epistruct/.
33. Boelle P-Y, Ansart S, Valleron A-J. 2011 Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respir. Viruses 5, 306-316. (doi:10.1111/j.1750-2659.2011.00234.x)
34. Nicoll A, Coulombier D. 2009 Europe's initial experience with pandemic (H1N1) 2009 - mitigating and delaying policies and practices. Euro Surveill. 14, pii=19279.
35. Kelso J, Halder N, Milne G. 2010 The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. PLoS ONE 5, e13797. (doi:10.1371/journal.pone. 0013797)
36. Moss R, McCaw J, McVernon J. 2011 Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic. PLoS ONE 6, e14505. (doi:10.1371/journal.pone.0014505)
37. Jefferson T, Jones M, Doshi P, Mar CD. 2009 Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Br. Med. J. 339, b5106. (doi:10.1136/bmj.b5106)
38. Alexander M, Moghadas S, Röst G, Wu J. 2008 A delay differential model for pandemic influenza with antiviral treatment. Bull. Math. Biol. 70, 382-397. (doi:10.1007/s11538-007-9257-2)
39. Danon L, House T, Read JM, Keeling MJ. 2012 Social encounter networks: collective properties and disease transmission. J. R. Soc. Interface 9, 2826-2833. (doi:10.1098/rsif.2012.0357)